NovoCure NVCR Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's operating lease right-of-use assets in other assets?
- NovoCure (NVCR) reported operating lease right-of-use assets in other assets of $45.48M in Q1 2026.
- How has NovoCure's operating lease right-of-use assets in other assets changed year-over-year?
- NovoCure's operating lease right-of-use assets in other assets decreased by 6.3% year-over-year, from $48.51M to $45.48M.
- What is the long-term trend for NovoCure's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), NovoCure's operating lease right-of-use assets in other assets has grown at a 20.0% compound annual growth rate (CAGR), from $19.01M to $47.33M.